The most common ways to record from or to stimulate the brain use electrodes that are placed on the surface of the scalp, the surface of the brain, or beneath the brain. These traditional recording/stimulation methods are either imprecise, require brain surgery, and/or do not provide stable long-term function. In contrast, Synchron’s device, the stentrode™, is a minimally invasive device; it consists of a stent (8 mm diameter) with embedded electrodes that is inserted into the superior sagittal sinus in the brain via the jugular vein. In 2020, the FDA awarded the stentrode™ the Breakthrough Device Designation. In 2021, Synchron became the first company to receive an FDA IDE to conduct trials of a permanently implantable BMI.
Synchron’s technology sets our to transform neuroprosthetics, neuromodulation, and neurodiagnostics.